Skip to content
OpenCapital
Get started

Establishment Labs ESTA Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

AbbVie logo
AbbVieABBV
——

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio3×-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's indefinite- lived intangible impairment?
Establishment Labs (ESTA) reported indefinite- lived intangible impairment of $21.94M in Q1 2026.
How has Establishment Labs's indefinite- lived intangible impairment changed year-over-year?
Establishment Labs's indefinite- lived intangible impairment increased by 3.4% year-over-year, from $21.21M to $21.94M.
What is the long-term trend for Establishment Labs's indefinite- lived intangible impairment?
Over 5 years (2020 to 2025), Establishment Labs's indefinite- lived intangible impairment has grown at a 25.6% compound annual growth rate (CAGR), from $6.97M to $21.79M.